ENTEHEP
Main information
- Trade name:
- ENTEHEP 10 TAB
- Active ingredient:
- ENTECAVIR
- Available from:
- Zydus Cadila
- Dosage:
- 0.5MG
- Pharmaceutical form:
- TAB
- Composition:
- 10
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
10-10-2017
Human medicines European public assessment report (EPAR): Entecavir Mylan, entecavir, Revision: 0, Authorised
Europe - EMA - European Medicines Agency
21-7-2017
Pending EC decision: Entecavir Accord, entecavir, Opinion date: 20-Jul-2017
Europe - EMA - European Medicines Agency
21-7-2017
Pending EC decision: Entecavir Mylan, entecavir, Opinion date: 20-Jul-2017
Europe - EMA - European Medicines Agency
2-4-2018
![ENTECAVIR (Telmisartan And Hydrochlorothiazide) Tablet, Film Coated [Solco Healthcare LLC]](/web/assets/global/img/flags/us.png)
ENTECAVIR (Telmisartan And Hydrochlorothiazide) Tablet, Film Coated [Solco Healthcare LLC]
Updated Date: Apr 2, 2018 EST
US - DailyMed
19-3-2018
ENTECAVIR Tablet [Breckenridge Pharmaceutical, Inc.]
Updated Date: Mar 19, 2018 EST
US - DailyMed
15-2-2018
ENTECAVIR Tablet, Film Coated [Accord Healthcare Inc.]
Updated Date: Feb 15, 2018 EST
US - DailyMed
11-12-2017
BARACLUDE (Entecavir) Tablet, Film Coated BARACLUDE (Entecavir) Solution [E.R. Squibb Sons, L.L.C.]
Updated Date: Dec 11, 2017 EST
US - DailyMed
28-9-2017
Entecavir Accord (Accord Healthcare Limited)
Entecavir Accord (Active substance: entecavir) - Centralised - Authorisation - Commission Decision (2017)6645 of Thu, 28 Sep 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/004458/0000
Europe -DG Health and Food Safety
22-9-2017
ENTECAVIR Tablet, Film Coated [Teva Pharmaceuticals USA, Inc.]
Updated Date: Sep 22, 2017 EST
US - DailyMed
20-9-2017
Entecavir Mylan (Mylan S.A.S.)
Entecavir Mylan (Active substance: entecavir) - Centralised - Authorisation - Commission Decision (2017)6407 of Wed, 20 Sep 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/004377/0000
Europe -DG Health and Food Safety
10-8-2017
ENTECAVIR Tablet, Film Coated [Cadila Healthcare Limited]
Updated Date: Aug 10, 2017 EST
US - DailyMed
10-8-2017
ENTECAVIR Tablet, Film Coated [Zydus Pharmaceuticals (USA) Inc.]
Updated Date: Aug 10, 2017 EST
US - DailyMed
7-7-2017
ENTECAVIR Tablet [Camber Pharmaceuticals, Inc.]
Updated Date: Jul 7, 2017 EST
US - DailyMed
23-6-2017
ENTECAVIR Tablet, Coated [Par Pharmaceutical Inc.]
Updated Date: Jun 23, 2017 EST
US - DailyMed
21-6-2017
ENTECAVIR Tablet, Film Coated [Par Pharmaceutical Inc.]
Updated Date: Jun 21, 2017 EST
US - DailyMed
15-6-2017
ENTECAVIR Tablet, Film Coated [NorthStar RxLLC]
Updated Date: Jun 15, 2017 EST
US - DailyMed
26-1-2017
Human medicines European public assessment report (EPAR): Entecavir Accord, entecavir, Revision: 0, Authorised
Europe - EMA - European Medicines Agency